| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T55 |
231-241 |
MESH:D000086402 |
denotes |
SARS-CoV-2 |
| T54 |
257-260 |
CHEBI:33697 |
denotes |
RNA |
| T3 |
257-266 |
MESH:D012328 |
denotes |
RNA virus |
| T4 |
285-291 |
HP:0012828 |
denotes |
severe |
| T86 |
285-317 |
MESH:D045169 |
denotes |
severe acute respiratory disease |
| T5 |
292-297 |
HP:0011009 |
denotes |
acute |
| T58 |
298-317 |
DOID:1579 |
denotes |
respiratory disease |
| T61 |
298-317 |
HP:0002795 |
denotes |
respiratory disease |
| T74 |
327-335 |
MESH:D000086382 |
denotes |
COVID-19 |
| T59 |
327-335 |
DOID:0080600 |
denotes |
COVID-19 |
| T62 |
327-335 |
HP:0033141 |
denotes |
COVID-19 |
| T87 |
346-354 |
MESH:D000086382 |
denotes |
COVID-19 |
| T10 |
346-354 |
DOID:0080600 |
denotes |
COVID-19 |
| T63 |
346-354 |
HP:0033141 |
denotes |
COVID-19 |
| T64 |
374-391 |
DOID:850 |
denotes |
pulmonary disease |
| T65 |
374-391 |
HP:0002795 |
denotes |
pulmonary disease |
| T66 |
374-391 |
MESH:D008171 |
denotes |
pulmonary disease |
| T14 |
398-406 |
MESH:D010361 |
denotes |
patients |
| T15 |
412-418 |
HP:0012828 |
denotes |
severe |
| T67 |
419-440 |
HP:0001626 |
denotes |
cardiovascular damage |
| T68 |
507-524 |
HP:0001637 |
denotes |
myocardial injury |
| T17 |
525-535 |
MESH:D015415 |
denotes |
biomarkers |
| T19 |
591-596 |
MESH:D003643 |
denotes |
death |
| T20 |
600-608 |
MESH:D010361 |
denotes |
patients |
| T75 |
614-622 |
MESH:D000086382 |
denotes |
COVID-19 |
| T21 |
614-622 |
DOID:0080600 |
denotes |
COVID-19 |
| T69 |
614-622 |
HP:0033141 |
denotes |
COVID-19 |
| T23 |
757-767 |
MESH:D015415 |
denotes |
biomarkers |
| T24 |
821-830 |
MESH:D017741 |
denotes |
survivors |
| T76 |
834-842 |
MESH:D000086382 |
denotes |
COVID-19 |
| T77 |
834-842 |
HP:0033141 |
denotes |
COVID-19 |
| T25 |
834-842 |
DOID:0080600 |
denotes |
COVID-19 |
| T89 |
951-955 |
MESH:D012306 |
denotes |
risk |
| T88 |
997-1018 |
MESH:D016001 |
denotes |
confidence intervals. |
| T30 |
1085-1106 |
MESH:D012189 |
denotes |
retrospective studies |
| T31 |
1133-1141 |
MESH:D010361 |
denotes |
patients |
| T32 |
1147-1156 |
MESH:D017741 |
denotes |
survivors |
| T70 |
1285-1295 |
MESH:D019210 |
denotes |
troponin I |
| T72 |
1319-1338 |
CHEBI:80233 |
denotes |
natriuretic peptide |
| T34 |
1344-1352 |
CHEBI:16919 |
denotes |
creatine |
| T35 |
1344-1352 |
MESH:D003401 |
denotes |
creatine |
| T81 |
1368-1389 |
MESH:D018376 |
denotes |
cardiac complications |
| T37 |
1421-1425 |
MESH:D012306 |
denotes |
risk |
| T39 |
1429-1434 |
MESH:D003643 |
denotes |
death |
| T40 |
1439-1447 |
MESH:D010361 |
denotes |
patients |
| T73 |
1453-1473 |
HP:0033141 |
denotes |
SARS-CoV-2 infection |
| T78 |
1453-1473 |
MESH:D000086382 |
denotes |
SARS-CoV-2 infection |
| T42 |
1453-1473 |
DOID:0080600 |
denotes |
SARS-CoV-2 infection |
| T82 |
1521-1546 |
MESH:D018376 |
denotes |
cardiovascular conditions |
| T44 |
1579-1589 |
MESH:D015415 |
denotes |
biomarkers |
| T79 |
1597-1605 |
MESH:D000086382 |
denotes |
COVID-19 |
| T80 |
1597-1605 |
HP:0033141 |
denotes |
COVID-19 |
| T45 |
1597-1605 |
DOID:0080600 |
denotes |
COVID-19 |
| T48 |
1621-1626 |
HP:0011009 |
denotes |
acute |
| T85 |
1627-1656 |
HP:0030872 |
denotes |
cardiovascular decompensation |
| T49 |
1676-1685 |
MESH:D009026 |
denotes |
mortality |
| T83 |
1689-1709 |
HP:0033141 |
denotes |
SARS-CoV-2 infection |
| T84 |
1689-1709 |
MESH:D000086382 |
denotes |
SARS-CoV-2 infection |
| T51 |
1689-1709 |
DOID:0080600 |
denotes |
SARS-CoV-2 infection |
| T53 |
1729-1737 |
MESH:D012106 |
denotes |
research |
